|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 331.70 CHF | -0.75% |
|
+0.30% | +1.07% |
| 20/07 | Zonebourse corporate earnings calendar: week of July 20 to 24, 2026 | |
| 20/07 | Wall Street's Patience Runs Thin |
Company Valuation: Roche Holding AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,06,810 | 2,39,812 | 1,97,073 | 2,05,191 | 2,62,098 | 2,64,429 | - | - |
| Change | - | -21.84% | -17.82% | 4.12% | 27.73% | 0.89% | - | - |
| Enterprise Value (EV) 1 | 3,24,977 | 2,55,396 | 2,15,772 | 2,22,528 | 2,78,258 | 2,74,984 | 2,68,345 | 2,60,704 |
| Change | - | -21.41% | -15.51% | 3.13% | 25.04% | -1.18% | -2.41% | -2.85% |
| P/E | 23.4x | 18.9x | 17.1x | 24.8x | 20.5x | 17.7x | 16.5x | 15.1x |
| PBR | 13.2x | 8.29x | 5.91x | 5.67x | 7.8x | 6.56x | 5.53x | 4.7x |
| PEG | - | -3.69x | -2.48x | -0.9x | 0.4x | 1.1x | 2.21x | 1.69x |
| Capitalization / Revenue | 4.89x | 3.79x | 3.36x | 3.39x | 4.26x | 4.22x | 4.05x | 3.86x |
| EV / Revenue | 5.17x | 4.04x | 3.67x | 3.68x | 4.52x | 4.39x | 4.11x | 3.81x |
| EV / EBITDA | 13.2x | 10.2x | 9.82x | 9.45x | 11.3x | 10.8x | 9.9x | 9.05x |
| EV / EBIT | 14.8x | 11.5x | 11.2x | 10.7x | 12.7x | 12.2x | 11.1x | 10.1x |
| EV / FCF | 20.7x | 19.6x | 19.1x | 14.5x | 23.6x | 17.8x | 16.6x | 14.9x |
| FCF Yield | 4.83% | 5.11% | 5.23% | 6.89% | 4.24% | 5.63% | 6.04% | 6.7% |
| Dividend per Share 2 | 9.3 | 9.5 | 9.6 | 9.7 | 9.8 | 10.01 | 10.25 | 10.53 |
| Rate of return | 2.45% | 3.27% | 3.93% | 3.8% | 2.99% | 3.02% | 3.09% | 3.17% |
| EPS 2 | 16.2 | 15.37 | 14.31 | 10.31 | 16.04 | 18.72 | 20.11 | 21.91 |
| Distribution rate | 57.4% | 61.8% | 67.1% | 94.1% | 61.1% | 53.5% | 51% | 48% |
| Net sales 1 | 62,801 | 63,281 | 58,716 | 60,495 | 61,516 | 62,600 | 65,285 | 68,420 |
| EBITDA 1 | 24,692 | 25,015 | 21,976 | 23,538 | 24,608 | 25,403 | 27,106 | 28,820 |
| EBIT 1 | 21,897 | 22,173 | 19,240 | 20,823 | 21,833 | 22,592 | 24,172 | 25,728 |
| Net income 1 | 13,930 | 12,421 | 11,498 | 8,277 | 12,880 | 15,225 | 16,347 | 17,569 |
| Net Debt 1 | 18,167 | 15,584 | 18,699 | 17,337 | 16,160 | 10,555 | 3,915 | -3,725 |
| Reference price 2 | 379.10 | 290.50 | 244.50 | 255.50 | 328.20 | 331.70 | 331.70 | 331.70 |
| Nbr of stocks (in thousands) | 8,00,952 | 8,00,579 | 7,98,652 | 7,96,789 | 7,96,317 | 7,95,618 | - | - |
| Announcement Date | 03/02/22 | 02/02/23 | 01/02/24 | 30/01/25 | 29/01/26 | - | - | - |
1CHF in Million2CHF
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 17.72x | 4.39x | 10.82x | 3.02% | 33TCr | ||
| 34.09x | 12.2x | 25.51x | 0.59% | 1,02300Cr | ||
| 26.74x | 6.1x | 16.7x | 2.16% | 60TCr | ||
| 33.01x | 7.5x | 15.37x | 2.71% | 45TCr | ||
| 21.23x | 5.45x | 13.2x | 2.93% | 28TCr | ||
| 20.75x | 4.38x | 12.12x | 2.01% | 26TCr | ||
| 14.46x | 5.38x | 11.08x | 3.46% | 22TCr | ||
| 23.89x | 6.31x | 11.13x | 2.77% | 20TCr | ||
| -47.99x | 5.74x | 31.73x | 2.44% | 17TCr | ||
| 12.57x | 3.08x | 7.79x | 6.97% | 14TCr | ||
| Average | 15.65x | 6.05x | 15.55x | 2.91% | 36.56TCr | |
| Weighted average by Cap. | 23.09x | 7.49x | 17.58x | 2.22% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ROP Stock
- Valuation Roche Holding AG
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















